Calcium antagonists prevent cardiac morbidity in iron overload

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1410, 2003-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcium antagonists beneficial in cardiac surgery?

By  

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Long-Term Chelation Therapy with Deferasirox: Effects on Cardiac Iron Overload Measured by T2* MRI

By >   Borsellino Zelia   Cuccia Liana   >   Gagliardotto Francesco   Tarantino Rossana  

Clinical Drug Investigation, Vol. 30, Iss. 4, 2010-04 ,pp. : 267-273

Adis International

Access to resources Recommend Favorite

Deferasirox dominates deferoxamine for iron overload

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 665, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of iron overload in thalassaemic patients

By Ceci Adriana   Felisi Mariagrazia   De Sanctis Vincenzo   De Mattia Domenico  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1763-1774

Informa Healthcare

Access to resources Recommend Favorite

Effects of Enalapril in Rats With Pressure Overload Cardiac Hypertrophy

By Eugenio D.D.P.   Pietro G.   Rosario M.   De Sarro G.  

General Pharmacology, Vol. 28, Iss. 4, 1997-04 ,pp. : 531-533

Elsevier

Access to resources Recommend Favorite